Welcome to NTAP.
NTAP is on a mission to accelerate the discovery of useful therapies for people with cutaneous and plexiform neurofibromas. We know these discoveries will impact an even wider field of NF1 and Ras-related diseases.
In NTAP’s first decade we have already changed the field of NF1 science. As a top source of international research funding, we are driving new collaborations between industry and academics, convening world-class scientists in global symposiums, and seeding a new generation of research leaders. NTAP funding and oversight supported the clinical trial for what became the first approved therapy for NF1, and did it in record time. We are continuously building tools, models and data necessary for new discoveries and we are making them available for free in almost all situations.
As we enter our second decade, we are dedicated to continuing the work and enlarging the field of NF1 research. We are looking for new collaborators and welcome inquiries from industry, academia, the media and beyond. If you are interested in exploring any aspect of the science of NF1, including the critical role Ras plays in so many cancers, we want to hear from you.
With so many thanks,
Jaishri Blakeley
